114 related articles for article (PubMed ID: 9308074)
1. The association carbamazepine-mianserin in opiate withdrawal: a double blind pilot study versus clonidine.
Bertschy G; Bryois C; Bondolfi G; Velardi A; Budry P; Dascal D; Martinet C; Baettig D; Baumann P
Pharmacol Res; 1997 May; 35(5):451-6. PubMed ID: 9308074
[TBL] [Abstract][Full Text] [Related]
2. Topiramate in opiate withdrawal- comparison with clonidine and with carbamazepine/mianserin.
Zullino DF; Krenz S; Zimmerman G; Miozzari A; Rajeswaran R; Kolly S; Khazaal Y
Subst Abus; 2004 Dec; 25(4):27-33. PubMed ID: 16172090
[TBL] [Abstract][Full Text] [Related]
3. The efficiency of a carbamazepine-mianserin combination scheme in opiate detoxification.
Zullino DF; Krenz S; Favrat B; Zimmermann G; Bertschy G; Besson J
Hum Psychopharmacol; 2004 Aug; 19(6):425-30. PubMed ID: 15303247
[TBL] [Abstract][Full Text] [Related]
4. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin.
Oreskovich MR; Saxon AJ; Ellis ML; Malte CA; Reoux JP; Knox PC
Drug Alcohol Depend; 2005 Jan; 77(1):71-9. PubMed ID: 15607843
[TBL] [Abstract][Full Text] [Related]
6. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases.
Goodman WK; Charney DS; Price LH; Woods SW; Heninger GR
Am J Psychiatry; 1986 Jul; 143(7):900-3. PubMed ID: 2872826
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
[TBL] [Abstract][Full Text] [Related]
8. Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD.
Nair V; Mahadevan S
J Trop Pediatr; 2009 Apr; 55(2):116-21. PubMed ID: 19203986
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine in opiate withdrawal: a comparison with clonidine.
Nigam AK; Ray R; Tripathi BM
J Subst Abuse Treat; 1993; 10(4):391-4. PubMed ID: 8257551
[TBL] [Abstract][Full Text] [Related]
10. Comparison of acetorphan with clonidine for opiate withdrawal symptoms.
Hartmann F; Poirier MF; Bourdel MC; Loo H; Lecomte JM; Schwartz JC
Am J Psychiatry; 1991 May; 148(5):627-9. PubMed ID: 2018165
[TBL] [Abstract][Full Text] [Related]
11. Clonidine and opiate receptor antagonists in the treatment of heroin addiction.
Gerra G; Marcato A; Caccavari R; Fontanesi B; Delsignore R; Fertonani G; Avanzini P; Rustichelli P; Passeri M
J Subst Abuse Treat; 1995; 12(1):35-41. PubMed ID: 7752296
[TBL] [Abstract][Full Text] [Related]
12. A comparative clinical study of the effects of the traditional Chinese medicine Jinniu capsules and lofexidine on acute heroin withdrawal symptoms.
Shi J; Xu GZ; Liu TT; Wang X; Shen LY; Li J; Hao W; Chen HX; Li SX; Lu L
Am J Drug Alcohol Abuse; 2008; 34(6):792-800. PubMed ID: 19016185
[TBL] [Abstract][Full Text] [Related]
13. Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal.
Gold MS; Redmond DE; Kleber HD
Am J Psychiatry; 1979 Jan; 136(1):100-2. PubMed ID: 364997
[No Abstract] [Full Text] [Related]
14. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal.
Malcolm R; Ballenger JC; Sturgis ET; Anton R
Am J Psychiatry; 1989 May; 146(5):617-21. PubMed ID: 2653057
[TBL] [Abstract][Full Text] [Related]
15. Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal.
Akhondzadeh S; Ahmadi-Abhari SA; Assadi SM; Shabestari OL; Kashani AR; Farzanehgan ZM
J Clin Pharm Ther; 2000 Oct; 25(5):347-53. PubMed ID: 11123486
[TBL] [Abstract][Full Text] [Related]
16. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P
Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
[TBL] [Abstract][Full Text] [Related]
18. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
[TBL] [Abstract][Full Text] [Related]
19. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S
Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
[TBL] [Abstract][Full Text] [Related]
20. [Tizanidine in the treatment of acute withdrawal symptoms in heroin dependent patients].
Sós I; Kiss N; Csorba J; Gerevich J
Orv Hetil; 2000 Apr; 141(15):783-6. PubMed ID: 10808729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
